Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats

Veterinary Journal

Volumn 172, Issue 2, 2006, Pages 302-307

  Fernández Varón, Emilio ^a   Villamayor, Lucia ^a   Escudero, Elisa ^a   Espuny, Alberto ^a   Cárceles, Carlos M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Bioavailability; Intravenous; Milk; Moxifloxacin; Pharmacokinetics; Subcutaneous

Indexed keywords

MOXIFLOXACIN;

AREA UNDER THE CURVE; ARTICLE; BACTERIUM ISOLATE; COMPARTMENT MODEL; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG PENETRATION; FEMALE; FLUORESCENCE; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTATION; MILK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STEADY STATE;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; FEMALE; GOATS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LACTATION; MILK; QUINOLINES;

BACTERIA (MICROORGANISMS); CAPRA HIRCUS;

EID: 33746736972     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2005.04.017     Document Type: Article

References (26)

1. Abd El-Aty A.M., and Goudah A. Some pharmacokinetic parameters of pefloxacin in lactating goats. Veterinary Research Communications 26 (2002) 553-561
2. Abo El-Sooud K. Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats. Pharmacological Research 48 (2003) 389-395
3. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62 (2001) 1979-1989
4. Atkinson H., and Begg E. Prediction of drug distribution into human milk from physicochemical characteristics. Clinical Pharmacokinetics 18 (1990) 151-167
5. Brown S.A. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 1-14
6. Drusano G.L., Johnson D.E., Rosen M., and Standiford H. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37 (1993) 483-490
7. El-Banna H.A., and Abo El-Sooud K. Disposition kinetics of ciprofloxacin in lactating goats. Deutsche Tierärztliche Wochenschrift 105 (1998) 35-38
8. Gardner S.Y., Davis J.L., Jones S.L., Lafevers D.H., Hoskins M.S., Mcarver E.M., and Papich M.G. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 57-60
9. Gibaldi M., and Perrier P. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York
10. Lode H., Borner K., and Koeppe P. Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease 27 (1998) 33-39
11. Oukessou M., Benlamlich S., and Toutain P.L. Benzylpenicillin kinetics in the ewes: influence of pregnancy and lactation. Research in Veterinary Science 49 (1990) 190-193
12. Petraca K., Riond J.L., Graser T., and Wanner M. Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Journal of Veterinary Medicine A 40 (1993) 70-79
13. Powers J. Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics 13 (1990) 113-120
14. Sarasola P., Lees P., Aliabadi F.S., Mckellar Q.A., Donachie W., Marr K.A., Sunderland S.J., and Rowan T.G. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy 46 (2002) 3013-3019
15. Schneider M., Vallé M., Woehrlé F., and Boisramé B. Pharmacokinetics of Marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolates strains. Journal of Dairy Science 87 (2004) 202-211
16. Shem-Tov M., Ziv G., Glickman A., and Saran A. Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Zentralblatt für Veterinärmedizin A 44 (1997) 511-519
17. Siefert H.M., Kohlsdorfer C., Steinke W., and Witt A. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy 43 Suppl. B (1999) 61-67
18. Siefert H.M., Domdey-Bette A., Henninger F., Hucke F., Kohlsdorfer C., Steinke W., and Stass H.H. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. Journal of Antimicrobial Chemotherapy 43 Suppl. B (1999) 69-76
19. Soback S., Gips M., Bialer M., and Bor A. Effect of lactation on single dose pharmacokinetics of norfloxacin in ewes. Antimicrobial Agents and Chemotherapy 38 (1994) 2336-2339
20. Spreng M., Deleforge J., Thomas E., Boisrame B., and Drugeon H. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 284-289
21. Toutain P.L., and Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 467-477
22. Toutain P.L., Del Castillo J.R.E., and Bousquet-MéLou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73 (2002) 105-114
23. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58 (1999) 29-36
24. Waxman S., Rodríguez C., González F., De Vicente M.L., San Andrés M.I., and San Andrés M.D. Pharmacokinetics behavior of marbofloxacin after intravenous and intramuscular administration in adult goats. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 375-378
25. Woodcock J.M., Andrews J.M., and Boswell F.J. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 41 (1997) 101-106
26. Yamaoka K., Nakagawa T., and Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 6 (1978) 165-175